Zegfrovy 150 mg Tablet
Zegfrovy 150 mg is a targeted EGFR inhibitor for treating non-small cell lung cancer with EGFR exon 20 insertion mutations.
- The description claims advanced precision therapy.
AI Readiness
Good foundation, but some important product data is still missing.
63%